We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
(+2.6%)
Cap. Flow
-$89M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$48.8M |
| 2 |
Procter & Gamble
PG
|
+$24.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$23.6M |
| 4 |
Keysight
KEYS
|
+$23.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$46.5M |
| 2 |
ExxonMobil
XOM
|
+$36.6M |
| 3 |
GG
Goldcorp Inc
GG
|
+$24.9M |
| 4 |
Walt Disney
DIS
|
+$23.8M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.16% |
| 2 | Technology | 16.87% |
| 3 | Financials | 10.38% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETFC
276
DELISTED
E*Trade Financial Corporation
ETFC
| $6.31M | 0.08% |
142,041
+18,097
| +15% | +$864K |
|
277
CME Group
CME
$92.2B
| $6.21M | 0.08% |
26,714
-3,026
| -10% | -$558K |
|
278
iShares MSCI Canada ETF
EWC
$6.04B
| $6.19M | 0.08% |
217,225
-7,524
| -3% | -$212K |
|
279
Crown Castle
CCI
$32.7B
| $6.1M | 0.08% |
46,993
+14,893
| +46% | +$1.92M |
|
|
VIAB
280
DELISTED
Viacom Inc. Class B
VIAB
| $6.09M | 0.08% |
204,753
-122,938
| -38% | -$3.59M |
|
281
Take-Two Interactive
TTWO
$43B
| $6.07M | 0.08% |
53,692
+2,845
| +6% | +$293K |
|
282
Progressive
PGR
$124B
| $6.07M | 0.08% |
76,240
-30,308
| -28% | -$2.34M |
|
283
Norwegian Cruise Line
NCLH
$8.89B
| $6.06M | 0.08% |
113,444
+45,727
| +68% | +$2.54M |
|
|
LEXEA
284
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $6.05M | 0.08% |
+127,236
| New | +$5.62M |
|
|
VAR
285
DELISTED
Varian Medical Systems, Inc.
VAR
| $6.04M | 0.08% |
44,527
+10,269
| +30% | +$1.37M |
|
286
Qorvo
QRVO
$7.63B
| $5.99M | 0.07% |
90,384
-10,196
| -10% | -$709K |
|
287
TG Therapeutics
TGTX
$8.58B
| $5.96M | 0.07% |
692,000
| – | – |
|
288
Cheniere Energy
LNG
$56.5B
| $5.87M | 0.07% |
86,111
+60,672
| +238% | +$4.02M |
|
289
Ford
F
$57.3B
| $5.82M | 0.07% |
284,366
-128,935
| -31% | -$1.27M |
|
|
WBA
290
DELISTED
Walgreens Boots Alliance
WBA
| $5.79M | 0.07% |
83,270
-11,207
| -12% | -$596K |
|
291
Canadian National Railway
CNI
$78.3B
| $5.77M | 0.07% |
62,480
-20,454
| -25% | -$1.88M |
|
292
VF Corp
VFC
$6.68B
| $5.72M | 0.07% |
65,761
+2,919
| +5% | +$251K |
|
293
PVH
PVH
$3.71B
| $5.71M | 0.07% |
60,569
+21,381
| +55% | +$2.36M |
|
294
Humana
HUM
$46.7B
| $5.7M | 0.07% |
21,591
-5,342
| -20% | -$1.35M |
|
295
Pinduoduo
PDD
$118B
| $5.67M | 0.07% |
276,000
-193,600
| -41% | -$4.19M |
|
296
eBay
EBAY
$48.6B
| $5.61M | 0.07% |
142,696
-42,055
| -23% | -$1.58M |
|
|
ADSW
297
DELISTED
Advanced Disposal Services Inc
ADSW
| $5.61M | 0.07% |
+176,517
| New | +$5.55M |
|
298
Suncor Energy
SU
$77.7B
| $5.6M | 0.07% |
104,780
-67,446
| -39% | -$2.16M |
|
299
F5
FFIV
$22.1B
| $5.52M | 0.07% |
38,064
-3,844
| -9% | -$575K |
|
300
Cencora
COR
$60.3B
| $5.5M | 0.07% |
52,695
+24,394
| +86% | +$1.93M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2019 Portfolio in Review
As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
- Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
- Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
- Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
- Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
- Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
- Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.
Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.